FOR IMMEDIATE RELEASE
April 20, 2020
MCH Contact: Trevor Tankersley
Director of Public Relations
432-640-1249 | email@example.com
Vitalant Contact: Carla Alexander
Marketing & Communications Mgr
915-702-3374 | firstname.lastname@example.org
PLASMA DONATIONS FROM RECOVERED COVID-19 PATIENTS NEEDED TO HELP THE CRITICALLY ILL
Vitalant joins Medical Center Health System to Collect Convalescent Plasma
ODESSA, TX – 04/20/2020 – Vitalant has launched a program to treat COVID-19 patients with blood plasma donated by people who have recovered from the disease. Known as “convalescent plasma,” this blood component contains antibodies that may give patients an extra boost to fight their illness. In coordination with Medical Center Health System, Vitalant is working to identify willing donors who qualify for this type of donation.
“As the world looks for ways to fight this deadly virus, we’re proud to be partnering with Vitalant in an effort to successfully treat COVID-19 patients,” said Russell Tippin, President & CEO, Medical Center Health System. “We’ll continue to do what’s necessary to make sure COVID-19 patients receive the most up-to-date care in this relentless battle.”
Currently, there are no vaccines or proven treatments for COVID-19 because the virus is so new. Although trials for a vaccine are underway, it is expected to be many months before one is approved. The Food and Drug Administration (FDA) has identified and approved convalescent plasma treatment as an “emergency investigational new drug.” It is currently the only antibody treatment available to COVID-19 patients and, as such, is a promising new tool.
This form of investigational treatment may give the body more fight against COVID-19 by using antibodies that are active against the disease. With the help of our local communities, hospital partners and extensive research experience, Vitalant is gearing up to help patients fight this novel infectious disease with the help of willing recovered COVID-19 patients.
“By donating convalescent plasma, a donor potentially may save the lives of several COVID-19 patients”, states Dr. Liz Rosenbaum, Medical Director for Vitalant, South.
Vitalant is seeking convalescent plasma donors to help patients. Eligibility criteria are:
Prior diagnosis of COVID-19, documented by a laboratory test
Complete resolution of symptoms for at least 14 days
Meet all other current FDA donor eligibility requirements to donate plasma
Even with these requirements, there may be additional tests or other criteria required. In some instances, those who have recovered from COVID-19 may be able to donate, even if they did not have
an initial laboratory test. Those who meet that criteria and want to donate plasma are encouraged to apply through the Vitalant website Vitalant.org/covidfree. For more information, please call 866-CV-PLSMA (866-287-5762).
“As this life-transforming program continues to expand, we’re putting out a call to those who have recovered from COVID-19 to help patients in need,” said Cliff Numark, Vitalant’s chief of marketing. “We encourage those who are eligible to go through the process to make a real difference.”
Vitalant will only accept donors who meet all FDA-required donor eligibility criteria and are symptom-free for at least 14 days. Potential donors can only donate if they have applied and have been accepted to the program. Donors cannot walk in for this procedure; they must first fill out the form at Vitalant.org/covidfree to begin the application process. Potential donors will then be contacted by Vitalant.